ask="23.18"
ask_size="1000"
average_daily_volume="420885"
bid="21.21"
bid_size="100"
book_value="3.21"
change="-0.55"
change_from_200_day_moving_average="7.06"
change_from_50_day_moving_average="1.78"
change_from_52_week_high="-2.11"
change_From_52_week_low="16.10"
change_in_percent="-2.48%"
close="21.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="22.91"
high_52_weeks="23.75"
last_trade_date="3/2/2017"
last_trade_price="21.64"
last_trade_size="4089"
last_trade_time="4:00pm"
low="21.31"
low_52_weeks="5.54"
market_capitalization="215.38M"
moving_average_200_day="14.58"
moving_average_50_day="19.86"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="22.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+48.47%"
percent_change_from_50_day_moving_average="+8.96%"
percent_change_from_52_week_high="-8.88%"
percent_change_from_52_week_low="+290.61%"
previous_close="22.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.92"
price_per_sales="3907.31"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="468301"
weeks_range_52="5.54 - 23.75"
